Medicare Advantage Plans

Medicare Advantage (MA) is the privatized alternative to traditional Medicare, in which the federal government pays insurers a set amount per enrollee to administer benefits—often bundling in prescription drug coverage, dental, vision, and other extras. Roughly half of Medicare-eligible Americans now choose an MA plan, making it one of the most consequential and contested corners of U.S. health policy.

This hub matters now because the MA landscape is shifting quickly. Insurers are recalibrating provider networks and plan offerings amid tightening reimbursement rules and rising medical costs, sometimes leading hospital systems and physician groups to drop or renegotiate contracts with specific carriers. At the same time, new and unconventional entrants—including retail and membership-based companies—are moving into the space, signaling that competition for enrollees is intensifying beyond the traditional insurance giants. Regulatory scrutiny is also growing, as policymakers and watchdogs examine how MA plans are paid, marketed, and held accountable for the care they deliver.

Readers will find coverage here tracking annual enrollment changes, shifts in plan availability and benefits, the entry of new players into the market, network disputes between insurers and health systems, and policy debates over how MA is regulated and reimbursed. We also follow how upcoming enrollment cycles and rule changes affect what seniors can expect from their coverage, from drug plan restructuring to shifts in extra benefits. Whether you're a patient trying to make sense of your options, a provider navigating network changes, or an industry watcher tracking market consolidation, this page offers an ongoing view of how Medicare Advantage continues to reshape senior health coverage in the U.S.